Tissue Transglutaminase Test Market 2023 Top Players | SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH

The Global Tissue Transglutaminase Test Market is expected to grow at a CAGR of ~17.5% during the forecast period 2018-2023.

The tissue transglutaminase (tTG) testing is used for the diagnosis of certain autoimmune diseases, which is mostly restricted to celiac disease. In celiac disease, gluten (a protein found in wheat, barley, rye, and oats) is seen as a foreign invader and in response to it the body mounts an immune response to its enacting enzyme known as transglutaminase (which restricts the proteolysis of the glutin). tTG enzyme gets attacked by the (tTG) IgA and (tTG) IgG. For diagnostic purposes (tTG) IgA is exploited more frequently than the tTG (IgG) as tTG (IgG).

Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/824 .

Increasing prevalence of celiac disease drives the growth of the market. According to the World Gastroenterology Organization in 2016, 1% of the total population in western countries was diagnosed with the celiac diseases and the prevalence have substantially increased across the globe. According to Celiac Disease Foundation in 2016, hospitalization have increased by 600% from 1998 to 2013.

Increasing prevalence of autoimmune diseases mainly celiac disease, increasing geriatric global pool, and increasing investments healthcare drives the market growth. Low healthcare expenditure in developing regions, costs considerations, false positive diagnosis in geriatric population marked due to conditions such as diarrhoea, etc. likely to affect the market growth negatively.

Key Player

Some of key players profiled in the report are Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, Bio-Rad Laboratories, Inc., Pfizer Inc., Celimmune LLC., and others.

Segments

The global tissue transglutaminase testing market has been segmented on the basis types and end users.

Based on types, the market has been segmented into serological testing, biopsy, and others. The serological testing is sub-segmented into tissue transglutaminase (tTG) antibody- IgA, serum and Tissue Transglutaminase (tTG) antibody-IgG, serum, and others.

Based on the end users, the market has been segmented as hospitals & clinics, homecare, research organizations, and others.

Brief TOC

1.    Report Prologue

2.    Introduction

      2.1    Definition

      2.2    Scope of the Study

            2.2.1    Research Objective

            2.2.2    Assumptions

            2.2.3    Limitations

      2.3    Market Structure

      2.4.    Market Segmentation

Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/824 .

3.    Research Methodology

      3.1    Research Process

      3.2    Primary Research

      3.3    Secondary Research

      3.4    Market Size Estimation

      3.5    Forecast Model

4.    Market Dynamics

…TOC Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.